Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Name: Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
Author: Gilmore, James

Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting. — المؤلف: Gilmore, James — Journal of clinical pharmacology 20200619

المؤلف: Gilmore, James
النشر: Journal of clinical pharmacology 20200619
الوصف: 472-487 p.
الموضوعات: Antiemetics؛ Antineoplastic Agents؛ Biological Availability؛ Clinical Trials, Phase I as Topic؛ Clinical Trials, Phase II as Topic؛ Clinical Trials, Phase III as Topic؛ Drug Combinations؛ Humans